176 related articles for article (PubMed ID: 95055)
21. Lupus vulgaris resistant to streptomycin, isoniazid and thiacetazone. A case report.
Lal S; Garg BR; Hameedullah A
Indian J Dermatol; 1983 Jul; 28(3):117-9. PubMed ID: 6196282
[No Abstract] [Full Text] [Related]
22. Intermittent chemotherapy with thiacetazone and isoniazid in the treatment of pulmonary tuberculosis.
Krishnaswami KV
Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):177-87. PubMed ID: 77844
[No Abstract] [Full Text] [Related]
23. Thiacetazone skin reaction in Papua New Guinea.
Naraqi S; Temu P
Med J Aust; 1980 May; 1(10):480-1. PubMed ID: 6157976
[TBL] [Abstract][Full Text] [Related]
24. [The therapeutic efficacy of a streptomycin-hydrazide-thiacetazone regimen with different dosages of thiacetazone in pulmonary tuberculosis].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):72-6, 125. PubMed ID: 2427291
[No Abstract] [Full Text] [Related]
25. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
26. [Cutaneous side effects of antitumor chemotherapy].
Delaunay M
Ann Dermatol Venereol; 1989; 116(4):347-61. PubMed ID: 2528934
[No Abstract] [Full Text] [Related]
27. Value of isoniazid-thiacetazone combination in unsupervised ambulatory cases of pulmonary tuberculosis.
Narang RK
Indian Pract; 1967 Jul; 20(7):465-8. PubMed ID: 4169024
[No Abstract] [Full Text] [Related]
28. Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.
van Gorkom J; Kibuga DK
Tuber Lung Dis; 1996 Feb; 77(1):30-6. PubMed ID: 8733411
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.
Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J
Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647
[TBL] [Abstract][Full Text] [Related]
30. Thiacetazone: time to call a halt? Considerations on the use of thiacetazone in African populations with a high prevalence of human immunodeficiency virus infection.
Elliott AM; Foster SD
Tuber Lung Dis; 1996 Feb; 77(1):27-9. PubMed ID: 8733410
[No Abstract] [Full Text] [Related]
31. A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore: second report.
Tubercle; 1974 Dec; 55(4):251-60. PubMed ID: 4143454
[No Abstract] [Full Text] [Related]
32. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.
Hawken M; Nunn P; Gathua S; Brindle R; Godfrey-Faussett P; Githui W; Odhiambo J; Batchelor B; Gilks C; Morris J
Lancet; 1993 Aug; 342(8867):332-7. PubMed ID: 7687729
[TBL] [Abstract][Full Text] [Related]
33. Isoniazid with thiacetazone in the treatment of pulmonary tuberculosis in East Africa.
East Afr Med J; 1972 Jan; 49(1):3-6. PubMed ID: 4112873
[No Abstract] [Full Text] [Related]
34. Experience with thiacetazone chemotherapy for tuberculosis in the Sudan.
Mahdi ME
Tubercle; 1968 Mar; 49():Suppl:32-4. PubMed ID: 4173326
[No Abstract] [Full Text] [Related]
35. A clinical trial of thiacetazone-INH combination in pulmonary tuberculosis in children.
Krishnamurthy KA; Subramanian J
Indian Pediatr; 1968 Aug; 5(8):379-81. PubMed ID: 4182459
[No Abstract] [Full Text] [Related]
36. Is thiacetazone necessary or useful in the intensive phase of anti-tuberculous chemotherapy?
McLeod DT; Pringle D; Zingoni T; Mbengeranwa OL
Cent Afr J Med; 1989 Jan; 35(1):313-6. PubMed ID: 2472897
[TBL] [Abstract][Full Text] [Related]
37. Further consequences of thioacetazone-induced cutaneous reactions.
Lawn SD; Griffin GE
Int J Tuberc Lung Dis; 2000 Jan; 4(1):92-3. PubMed ID: 10654652
[No Abstract] [Full Text] [Related]
38. The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa.
Pozniak AL; MacLeod GA; Mahari M; Legg W; Weinberg J
AIDS; 1992 Aug; 6(8):809-14. PubMed ID: 1384557
[TBL] [Abstract][Full Text] [Related]
39. Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
Tubercle; 1970 Jun; 51(2):123-51. PubMed ID: 4099678
[No Abstract] [Full Text] [Related]
40. Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma.
Watkins WM; Mungai M; Muhia DK; Mberu EK; Gathua S; Winstanley PA; Gilks CF; Nunn P
Br J Clin Pharmacol; 1996 Feb; 41(2):160-2. PubMed ID: 8838444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
